Transgene
OverviewSuggest Edit
Transgene (Euronext: TNG),
part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cells. The Company’s two lead clinical-stage programs are: TG4010 for non-small cell lung cancer and Pexa-Vec for liver cancer. The Company has several other programs in clinical and pre-clinical development. Transgene is based in Strasbourg, France, and has additional operations in Lyon, as well as satellite offices in China and the U.S.
| Type | Public | |
| HQ | Illkirch, FR | Map |
| Website | transgene.fr |
Recent NewsAll News
- AstraZeneca ties up with France's Transgene to develop viral immunotherapies
- BioInvent and Transgene Extend Their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors
- Transgene Biotek reports standalone net loss of Rs 0.93 crore in the December 2018 quarter
- Gene Therapy Market to Set Phenomenal Growth from 2018 to 2026 Estimated by Global Top Players GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck KGaA, Transgene SA
Latest Updates
| Employees (est.) (Feb 2019) | 134 | |
| Job Openings | 3 |
Key People/Management at Transgene
Juan Pedro R. Serrate
Analyst
Transgene Office Locations
Transgene has offices in Illkirch, Lyon, Cambridge and Shanghai
Shanghai, CN
Rm 508, Building 2 4633, Pusan Road Kangqiao Industrial Park, Pudong Shanghai
Lyon, FR
321 Avenue Jean Jaurès
Cambridge, US
355 Main St #802
Transgene Online and Social Media Presence
1.2k Twitter followers
Transgene has 1.2k Twitter Followers. The number of followers has increased 0.1% month over month and increased 2.3% quarter over quarter
Transgene's Trends
Twitter Engagement Stats for @TransgeneSA
1.1k
Tweets
459
Following
1.2k
Followers
1
Tweets last 30 days
0
Avg. likes per Tweet
0%
Tweets with engagement
Transgene News and Updates
May 02, 2019
AstraZeneca ties up with France's Transgene to develop viral immunotherapies
British drugmaker AstraZeneca Plc
and French biopharmaceutical firm Transgene SA entered
into an agreement on Thursday to co-develop five cancer-killing
viral immunotherapies.
March 26, 2019
BioInvent and Transgene Extend Their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors
LUND, Sweden and STRASBOURG, France, March 26, 2019 /PRNewswire/ -- BioInvent International AB (OMXS: BINV), a biotech company focused on the discovery and development of novel immuno-regulatory antibodies to treat cancer and Transgene (Euronext Paris: TNG), a biotech company that designs ...
February 15, 2019
Transgene Biotek reports standalone net loss of Rs 0.93 crore in the December 2018 quarter
Reported sales nil
November 22, 2018
Gene Therapy Market to Set Phenomenal Growth from 2018 to 2026 Estimated by Global Top Players GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck KGaA, Transgene SA
#Summary: Summary This report includes market status and forecast of global and major regions, with the introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Posted via Industry Today. Follow us on Twi…
November 20, 2018
Transgene Biotek reports standalone net loss of Rs 2.67 crore in the September 2018 quarter
Reported sales nil
November 08, 2018
GDR issue: Sebi lifts market ban on Transgene Biotek's 2 promoters, director
Sebi has revoked market ban against Transgene Biotek's two promoters and a director, in a case related to alleged diversion of funds by the pharma firm through issuance of GDRs, as the regulator did not come across any adverse findings against them.
According to Sebi, there are no adverse findings a…
Transgene Blogs
April 18, 2019
The efficacy and safety of Tipapkinogen Sovacivec (TG4001) therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up
D. M. Harper, et al. Gynecologic Oncology, April 2019 [Publication]
Transgene Frequently Asked Questions
Who are Transgene key executives?
Transgene's key executives are Juan Pedro R. Serrate.
How many employees does Transgene have?
Transgene has 134 employees.
Who are Transgene competitors?
Competitors of Transgene include Innate Pharma, Magenta Therapeutics and Synthace.
Where are Transgene offices?
Transgene has offices in Illkirch, Lyon, Cambridge and Shanghai.
How many offices does Transgene have?
Transgene has 4 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies